Radio-frequency ablation of hepatocellular carcinoma before liver transplantation

A histologic and 'TUNEL' study

G. J. Netto, B. Altrabulsi, N. Katabi, P. Martin, K. Burt, M. Levy, E. Sanchez, D. L. Watkins, L. Jennings, G. Klintmalm, R. Goldstein

Research output: Contribution to journalArticle

Abstract

Background: Radio-frequency ablation (RFA) is an increasingly used treatment modality for hepatocellular carcinoma (HCC) in patients awaiting liver transplantation (OLTX). The current study evaluates the effectiveness of RFA in this setting based on evaluation of total cell death in explanted native livers. Design: We evaluated 36 tumors from 35 patients with RFA-treated HCC who underwent OLTX at our center between 1998 and 2002. Native livers from OLTX were extensively sampled for histologic evaluation. For each HCC, an estimate ratio of necrotic tumor areas was calculated based on hematoxylin and eosin (H&E) sections. In tumors with 10% or more residual viable areas, Tdt-mediated UTP nick-end labeling (TUNEL) was further performed to assess apoptosis in the morphologically 'viable' areas. A final 'tumor cell death' (TCD) ratio was recalculated for each HCC to include areas of apoptosis identified by TUNEL. Results: Based on H&E evaluation, 22/36 (61.1%) HCC revealed ≥90% necrosis including 12/36 HCC (33.3%) showing no evidence of residual viable tumor. The overall median tumor necrosis was 79%. When TUNEL findings were added, 26/36 (72.2%) HCC revealed ≥90% TCD including 14/36 HCC (38.8%) showing complete TCD (median TCD of 88.4%). None of our patients died of HCC while awaiting OLTX. Longer RFA-to-transplant time appears to be associated with a higher TCD rate (median of 154.5 days in patients with less than 90% TCD vs 326 days for patients with ≥90% TCD; P = 0.019). There was no significant correlation between tumor grade or pre-RFA size of the tumors and TCD rate in RFA-treated HCC (P = 0.11). Conclusion: Extensive TCD (88.4% me dian) can be obtained using RFA for HCC in patients awaiting OLTX. Our TUNEL findings suggest that RFA-induced cell injury could be associated with apoptosis.

Original languageEnglish (US)
Pages (from-to)746-751
Number of pages6
JournalLiver International
Volume26
Issue number6
DOIs
StatePublished - Aug 2006

Fingerprint

Uridine Triphosphate
Radio
Liver Transplantation
Hepatocellular Carcinoma
Cell Death
Neoplasms
Apoptosis
Necrosis
Mortality
Liver
Residual Neoplasm
Hematoxylin
Eosine Yellowish-(YS)

Keywords

  • Apoptosis
  • RFA-hepatoma
  • TUNEL

ASJC Scopus subject areas

  • Hepatology

Cite this

Netto, G. J., Altrabulsi, B., Katabi, N., Martin, P., Burt, K., Levy, M., ... Goldstein, R. (2006). Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: A histologic and 'TUNEL' study. Liver International, 26(6), 746-751. https://doi.org/10.1111/j.1478-3231.2006.01278.x

Radio-frequency ablation of hepatocellular carcinoma before liver transplantation : A histologic and 'TUNEL' study. / Netto, G. J.; Altrabulsi, B.; Katabi, N.; Martin, P.; Burt, K.; Levy, M.; Sanchez, E.; Watkins, D. L.; Jennings, L.; Klintmalm, G.; Goldstein, R.

In: Liver International, Vol. 26, No. 6, 08.2006, p. 746-751.

Research output: Contribution to journalArticle

Netto, GJ, Altrabulsi, B, Katabi, N, Martin, P, Burt, K, Levy, M, Sanchez, E, Watkins, DL, Jennings, L, Klintmalm, G & Goldstein, R 2006, 'Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: A histologic and 'TUNEL' study', Liver International, vol. 26, no. 6, pp. 746-751. https://doi.org/10.1111/j.1478-3231.2006.01278.x
Netto, G. J. ; Altrabulsi, B. ; Katabi, N. ; Martin, P. ; Burt, K. ; Levy, M. ; Sanchez, E. ; Watkins, D. L. ; Jennings, L. ; Klintmalm, G. ; Goldstein, R. / Radio-frequency ablation of hepatocellular carcinoma before liver transplantation : A histologic and 'TUNEL' study. In: Liver International. 2006 ; Vol. 26, No. 6. pp. 746-751.
@article{55ad5e2ececd4ae5adf8b9844567070f,
title = "Radio-frequency ablation of hepatocellular carcinoma before liver transplantation: A histologic and 'TUNEL' study",
abstract = "Background: Radio-frequency ablation (RFA) is an increasingly used treatment modality for hepatocellular carcinoma (HCC) in patients awaiting liver transplantation (OLTX). The current study evaluates the effectiveness of RFA in this setting based on evaluation of total cell death in explanted native livers. Design: We evaluated 36 tumors from 35 patients with RFA-treated HCC who underwent OLTX at our center between 1998 and 2002. Native livers from OLTX were extensively sampled for histologic evaluation. For each HCC, an estimate ratio of necrotic tumor areas was calculated based on hematoxylin and eosin (H&E) sections. In tumors with 10{\%} or more residual viable areas, Tdt-mediated UTP nick-end labeling (TUNEL) was further performed to assess apoptosis in the morphologically 'viable' areas. A final 'tumor cell death' (TCD) ratio was recalculated for each HCC to include areas of apoptosis identified by TUNEL. Results: Based on H&E evaluation, 22/36 (61.1{\%}) HCC revealed ≥90{\%} necrosis including 12/36 HCC (33.3{\%}) showing no evidence of residual viable tumor. The overall median tumor necrosis was 79{\%}. When TUNEL findings were added, 26/36 (72.2{\%}) HCC revealed ≥90{\%} TCD including 14/36 HCC (38.8{\%}) showing complete TCD (median TCD of 88.4{\%}). None of our patients died of HCC while awaiting OLTX. Longer RFA-to-transplant time appears to be associated with a higher TCD rate (median of 154.5 days in patients with less than 90{\%} TCD vs 326 days for patients with ≥90{\%} TCD; P = 0.019). There was no significant correlation between tumor grade or pre-RFA size of the tumors and TCD rate in RFA-treated HCC (P = 0.11). Conclusion: Extensive TCD (88.4{\%} me dian) can be obtained using RFA for HCC in patients awaiting OLTX. Our TUNEL findings suggest that RFA-induced cell injury could be associated with apoptosis.",
keywords = "Apoptosis, RFA-hepatoma, TUNEL",
author = "Netto, {G. J.} and B. Altrabulsi and N. Katabi and P. Martin and K. Burt and M. Levy and E. Sanchez and Watkins, {D. L.} and L. Jennings and G. Klintmalm and R. Goldstein",
year = "2006",
month = "8",
doi = "10.1111/j.1478-3231.2006.01278.x",
language = "English (US)",
volume = "26",
pages = "746--751",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Radio-frequency ablation of hepatocellular carcinoma before liver transplantation

T2 - A histologic and 'TUNEL' study

AU - Netto, G. J.

AU - Altrabulsi, B.

AU - Katabi, N.

AU - Martin, P.

AU - Burt, K.

AU - Levy, M.

AU - Sanchez, E.

AU - Watkins, D. L.

AU - Jennings, L.

AU - Klintmalm, G.

AU - Goldstein, R.

PY - 2006/8

Y1 - 2006/8

N2 - Background: Radio-frequency ablation (RFA) is an increasingly used treatment modality for hepatocellular carcinoma (HCC) in patients awaiting liver transplantation (OLTX). The current study evaluates the effectiveness of RFA in this setting based on evaluation of total cell death in explanted native livers. Design: We evaluated 36 tumors from 35 patients with RFA-treated HCC who underwent OLTX at our center between 1998 and 2002. Native livers from OLTX were extensively sampled for histologic evaluation. For each HCC, an estimate ratio of necrotic tumor areas was calculated based on hematoxylin and eosin (H&E) sections. In tumors with 10% or more residual viable areas, Tdt-mediated UTP nick-end labeling (TUNEL) was further performed to assess apoptosis in the morphologically 'viable' areas. A final 'tumor cell death' (TCD) ratio was recalculated for each HCC to include areas of apoptosis identified by TUNEL. Results: Based on H&E evaluation, 22/36 (61.1%) HCC revealed ≥90% necrosis including 12/36 HCC (33.3%) showing no evidence of residual viable tumor. The overall median tumor necrosis was 79%. When TUNEL findings were added, 26/36 (72.2%) HCC revealed ≥90% TCD including 14/36 HCC (38.8%) showing complete TCD (median TCD of 88.4%). None of our patients died of HCC while awaiting OLTX. Longer RFA-to-transplant time appears to be associated with a higher TCD rate (median of 154.5 days in patients with less than 90% TCD vs 326 days for patients with ≥90% TCD; P = 0.019). There was no significant correlation between tumor grade or pre-RFA size of the tumors and TCD rate in RFA-treated HCC (P = 0.11). Conclusion: Extensive TCD (88.4% me dian) can be obtained using RFA for HCC in patients awaiting OLTX. Our TUNEL findings suggest that RFA-induced cell injury could be associated with apoptosis.

AB - Background: Radio-frequency ablation (RFA) is an increasingly used treatment modality for hepatocellular carcinoma (HCC) in patients awaiting liver transplantation (OLTX). The current study evaluates the effectiveness of RFA in this setting based on evaluation of total cell death in explanted native livers. Design: We evaluated 36 tumors from 35 patients with RFA-treated HCC who underwent OLTX at our center between 1998 and 2002. Native livers from OLTX were extensively sampled for histologic evaluation. For each HCC, an estimate ratio of necrotic tumor areas was calculated based on hematoxylin and eosin (H&E) sections. In tumors with 10% or more residual viable areas, Tdt-mediated UTP nick-end labeling (TUNEL) was further performed to assess apoptosis in the morphologically 'viable' areas. A final 'tumor cell death' (TCD) ratio was recalculated for each HCC to include areas of apoptosis identified by TUNEL. Results: Based on H&E evaluation, 22/36 (61.1%) HCC revealed ≥90% necrosis including 12/36 HCC (33.3%) showing no evidence of residual viable tumor. The overall median tumor necrosis was 79%. When TUNEL findings were added, 26/36 (72.2%) HCC revealed ≥90% TCD including 14/36 HCC (38.8%) showing complete TCD (median TCD of 88.4%). None of our patients died of HCC while awaiting OLTX. Longer RFA-to-transplant time appears to be associated with a higher TCD rate (median of 154.5 days in patients with less than 90% TCD vs 326 days for patients with ≥90% TCD; P = 0.019). There was no significant correlation between tumor grade or pre-RFA size of the tumors and TCD rate in RFA-treated HCC (P = 0.11). Conclusion: Extensive TCD (88.4% me dian) can be obtained using RFA for HCC in patients awaiting OLTX. Our TUNEL findings suggest that RFA-induced cell injury could be associated with apoptosis.

KW - Apoptosis

KW - RFA-hepatoma

KW - TUNEL

UR - http://www.scopus.com/inward/record.url?scp=33745616776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745616776&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2006.01278.x

DO - 10.1111/j.1478-3231.2006.01278.x

M3 - Article

VL - 26

SP - 746

EP - 751

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 6

ER -